⌘K

Login Start Free

Home/Filings/4/0001214659-22-004373

4//SEC Filing

MOORE ALISON 4

Accession 0001214659-22-004373

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 5:51 PM ET

Size

5.4 KB

Accession

0001214659-22-004373

Insider Transaction Report

Form 4

Period: 2022-03-23

Allogene Therapeutics, Inc.ALLO

Chief Technical Officer

Transactions

Award
Stock Option (Right to Buy)
2022-03-23+737,179→ 737,179 total
Exercise: $9.69Exp: 2032-03-23→ Common Stock (737,179 underlying)

Footnotes (1)

[F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Documents

1 file

4
marketforms-55852.xmlPrimary
PRIMARY DOCUMENT

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001754937

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 5:51 PM ET
Size: 5.4 KB

View on SEC.gov